Home » Topics » Regulatory

Regulatory
RSS

FDA grants accelerated approval to Imfinzi for previously treated bladder cancer

May 2, 2017

FDA approves Stivarga for second-line treatment of hepatocellular carcinoma

April 28, 2017

FDA approves Brineura to treat CLN2 disease

April 28, 2017

FDA grants accelerated approval to Tecentriq for bladder cancer not treatable with cisplatin

April 18, 2017

FDA grants approval for Ingrezza capsules for adults with tardive dyskinesia

April 12, 2017

FDA approves Austedo to treat chorea associated with Huntington's disease

April 4, 2017

European Commission approves Tafinlar with Mekinist for BRAF V600-positive NSCLC

April 3, 2017

Munipharma's Mundesine capsules approved in Japan

April 3, 2017

FDA approves Dupixent for moderate to severe atopic dermatitis

March 29, 2017

FDA approves Ocrevus for relapsing and primary progressive forms of MS

March 29, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 22, 2025.
Coinfections and diversity paint the many shades of HIV cure
BioWorld
We all look different to HIV, a virus that destroys the immune system. The defensive cells record every interaction with foreign agents, infections from viruses...
Livzon’s IL-17A/F meets phase III endpoints in plaque psoriasis
BioWorld
Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted...
Sino to acquire Lanova and pipeline for up to $950M
BioWorld Asia
Sino Biopharmaceutical Ltd. agreed to fully acquire Lanova Medicines Ltd. by buying an additional 95.09% stake in Lanova at a valuation of up to $950.92 million....